Clinical Trials Directory

Trials / Terminated

TerminatedNCT04077372

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

A Randomized, Controlled Trial Examining the Use of The "Serious Illness Conversation Guide" (SICG) in Patients With Advanced Gastro-Intestinal Cancers

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine whether standardized implementation of a scripted template for discussing important issues that arise near the end of life improves the care of those who have advanced cancer.

Detailed description

Primary Objective: To determine whether the Serious Illness Conversation Guide will improve the consistency with which providers have and document conversations regarding patients' goals and priorities as they near the end of life. Secondary Objectives: 1. To assess whether having conversations as per this model will improve the quality of care near the end of life as determined by appropriate care in concordance with their goals of care. 2\. To assess whether having conversations as per this model will improve patient Quality of Life (QOL) as per a validated scale. 3\. To assess in patients with concordant care whether this model will improve patient QOL as per a validated scale 4. To assess provider opinions about end-of-life conversations.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSerious Illness Conversation Guide (SICG)The Serious Illness Conversation Guide (SICG) is a structured communication template designed to provide effective tool in initiating advanced care planning discussion with patients.
BEHAVIORALQuality of Life (QOL) surveyQuality of life survey by questionnaire (FACT-G) given every three months

Timeline

Start date
2019-09-16
Primary completion
2020-10-11
Completion
2020-10-11
First posted
2019-09-04
Last updated
2023-01-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04077372. Inclusion in this directory is not an endorsement.